Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

254.16
Delayed Data
As of Jul 27
 -1.99 / -0.78%
Today’s Change
184.50
Today|||52-Week Range
261.27
+21.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$85.4B

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
P:3538622617000
Investor Relations:
(862) 261-7558

Employees

Shareholders

Mutual fund holders45.56%
Other institutional41.66%
Individual stakeholders0.25%

Top Executives

Brenton L. SaundersChairman, President & Chief Executive Officer
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
C. David NicholsonChief Research & Development Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP